Additional file 6: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Additional file 4: Figure S2. of CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma

Li Li (14993)
Li Xu (108702)
Jing Yan (312090)
Zuo-Jun Zhen (642826)
Yong Ji (296783)
Chao-Qun Liu (642825)
Wan Lau (3485807)
Limin Zheng (385489)
Jing Xu (1234089)

October 2015

The number of CD15+, CD68+, CD3+, and S100+ cells in different regions of HCC tissues. Paraffin-embe...

Additional file 3 of Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis

Long Liu (390523)
Qi Wang (22418)
Linjun Wu (14680456)
Lele Zhang (388913)
Yuxi Huang (14160785)
Haihua Yang (728858)
Le guo (16550040)
Zheping Fang (16550043)
Xuequan Wang (697301)

July 2023

Additional Figure S2: (A) Co-expression analysis of POLA1 and POLA2; (B) ROC diagnostic curve of POL...

Additional file 2: of VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma

Ming Zhang (9736)
Hua-Jin Pang (5167337)
Wei Zhao (14321)
Yu-Fa Li (5167340)
Li-Xu Yan (223343)
Zhong-Yi Dong (5167343)
Xiao-Feng He (456180)

May 2018

Figure S1. Immunohistochemically staining of PD-L1 proteins in patients with hepatocellular carcinom...

Additional file 2: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing (6477710)
Yi-Peng Fu (6477713)
Yong Yi (147488)
Mei-Xia Zhang (6477716)
Su-Su Zheng (422272)
Jin-Long Huang (599641)
Wei Gan (172146)
Xin Xu (11989)
Jia-Jia Lin (6477719)
Juan Zhang (48597)
Shuang-Jian Qiu (157512)
Bo-Heng Zhang (422274)

March 2019

Table S2. Univariate and multivariate analyses of prognostic factors correlated with RFS (DOCX 16 kb

Additional file 5: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing (6477710)
Yi-Peng Fu (6477713)
Yong Yi (147488)
Mei-Xia Zhang (6477716)
Su-Su Zheng (422272)
Jin-Long Huang (599641)
Wei Gan (172146)
Xin Xu (11989)
Jia-Jia Lin (6477719)
Juan Zhang (48597)
Shuang-Jian Qiu (157512)
Bo-Heng Zhang (422274)

March 2019

Table S5. Infiltrating patterns of immune cells with different PD-L1 expression on IC (DOCX 16 kb

Additional file 4: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing (6477710)
Yi-Peng Fu (6477713)
Yong Yi (147488)
Mei-Xia Zhang (6477716)
Su-Su Zheng (422272)
Jin-Long Huang (599641)
Wei Gan (172146)
Xin Xu (11989)
Jia-Jia Lin (6477719)
Juan Zhang (48597)
Shuang-Jian Qiu (157512)
Bo-Heng Zhang (422274)

March 2019

Table S4. Correlation between PD-L1 expression on TC and different immune infiltrates (DOCX 16 kb

Additional file 3: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing (6477710)
Yi-Peng Fu (6477713)
Yong Yi (147488)
Mei-Xia Zhang (6477716)
Su-Su Zheng (422272)
Jin-Long Huang (599641)
Wei Gan (172146)
Xin Xu (11989)
Jia-Jia Lin (6477719)
Juan Zhang (48597)
Shuang-Jian Qiu (157512)
Bo-Heng Zhang (422274)

March 2019

Table S3. Correlation between HHLA2 expression and different immune infiltrates (DOCX 16 kb

Additional file 1: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing (6477710)
Yi-Peng Fu (6477713)
Yong Yi (147488)
Mei-Xia Zhang (6477716)
Su-Su Zheng (422272)
Jin-Long Huang (599641)
Wei Gan (172146)
Xin Xu (11989)
Jia-Jia Lin (6477719)
Juan Zhang (48597)
Shuang-Jian Qiu (157512)
Bo-Heng Zhang (422274)

March 2019

Table S1. Correlation between PD-L1 expression and baseline clinicopathological features in ICC (DOC...

HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing
Yi-Peng Fu
Yong Yi
Mei-Xia Zhang
Su-Su Zheng
Jin-Long Huang
Wei Gan
Xin Xu
Jia-Jia Lin
Juan Zhang
Shuang-Jian Qiu
Bo-Heng Zhang

March 2019

Abstract Background Intrahepatic cholangiocarcinoma (ICC) is a highly mortal malignancy with limited...

Additional file 5 of Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis

Long Liu (390523)
Qi Wang (22418)
Linjun Wu (14680456)
Lele Zhang (388913)
Yuxi Huang (14160785)
Haihua Yang (728858)
Le guo (16550040)
Zheping Fang (16550043)
Xuequan Wang (697301)

July 2023

Additional Figure S4: Immune cell type expression analysis results of POLA2 based on HPA, Monaco, an...

Additional file 1: of Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

Mark Kriegsmann (3485276)
Stephanie Roessler (479270)
Katharina Kriegsmann (6210830)
Marcus Renner (3097578)
Rémi Longuespée (3858949)
Thomas Albrecht (361635)
Moritz Loeffler (6210842)
Stephan Singer (3404138)
Arianeb Mehrabi (3097584)
Monika Vogel (6210848)
Anita Pathil (3097575)
Bruno Köhler (6210851)
Christoph Springfeld (6210854)
Christian Rupp (188332)
Karl Weiss (471420)
Benjamin Goeppert (539472)

January 2019

Figure S1. Example of a typical staining pattern of on-slide control tissues (PD-L1, SP263). Tonsill...

PD-L1 and HLA class i antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma

Sabbatino, Francesco
Villani, Vincenzo
Yearley, Jennifer H.
Deshpande, Vikram
Cai, Lei
Konstantinidis, Ioannis T.
Moon, Christina
Nota, Sjoerd
Wang, Yangyang
Al-Sukaini, Ahmad
Zhu, Andrew X.
Goyal, Lipika
Ting, David T.
Bardeesy, Nabeel
Hong, Theodore S.
Castillo, Carlos Fernandez-Del
Tanabe, Kenneth K.
Lillemoe, Keith D.
Ferrone, Soldano
Ferrone, Cristina R.

January 2016

Purpose: More effective therapy is needed for intrahepatic cholangiocarcinoma (ICC). The encouraging...

Additional file 2: Table S1. of PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma

Guanzhen Yu (781304)
Wenlong Yu (1600288)
Guangzhi Jin (3767215)
Dongyun Xu (3767218)
Ying Chen (9697)
Tian Xia (139140)
Allan Yu (3767221)
Wenzheng Fang (2098036)
Xiaoli Zhang (135098)
Zhaosheng Li (1465150)
Keping Xie (306727)

November 2015

Association between expression of PKM2, PFKB, and HK1 and clinical variables in HC patients. Table S...

Additional file 1: of Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling

Yan Wang (15435)
Yingjian Liang (300784)
Guangchao Yang (5225111)
Yaliang Lan (5225114)
Jihua Han (813010)
Jiabei Wang (345448)
Dalong Yin (345445)
Ruipeng Song (300788)
Tongsen Zheng (345447)
Shugeng Zhang (6050306)
Shangha Pan (201039)
Xirui Liu (5225102)
Mingxi Zhu (5225108)
Yao Liu (173014)
Yifeng Cui (5225105)
Fanzheng Meng (635696)
Bo Zhang (6559)
Shuhang Liang (6050309)
Hongrui Guo (6050312)
Yufeng Liu (307498)
Md Hassan (6050315)
Lianxin Liu (300790)

December 2018

Table S1. Target sequences of vshRNAs used in this study. Table S2. Primary antibodies for WB, IHC, ...

Additional file 2 of Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis

Long Liu (390523)
Qi Wang (22418)
Linjun Wu (14680456)
Lele Zhang (388913)
Yuxi Huang (14160785)
Haihua Yang (728858)
Le guo (16550040)
Zheping Fang (16550043)
Xuequan Wang (697301)

July 2023

Additional Figure S1: The high expression of POLA1 and POLA2 in hepatocellular carcinoma analyzed by...

Additional file 4: Figure S2. of CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma

Li Li (14993)
Li Xu (108702)
Jing Yan (312090)
Zuo-Jun Zhen (642826)
Yong Ji (296783)
Chao-Qun Liu (642825)
Wan Lau (3485807)
Limin Zheng (385489)
Jing Xu (1234089)

October 2015

The number of CD15+, CD68+, CD3+, and S100+ cells in different regions of HCC tissues. Paraffin-embe...

Additional file 3 of Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis

Long Liu (390523)
Qi Wang (22418)
Linjun Wu (14680456)
Lele Zhang (388913)
Yuxi Huang (14160785)
Haihua Yang (728858)
Le guo (16550040)
Zheping Fang (16550043)
Xuequan Wang (697301)

July 2023

Additional Figure S2: (A) Co-expression analysis of POLA1 and POLA2; (B) ROC diagnostic curve of POL...

Additional file 2: of VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma

Ming Zhang (9736)
Hua-Jin Pang (5167337)
Wei Zhao (14321)
Yu-Fa Li (5167340)
Li-Xu Yan (223343)
Zhong-Yi Dong (5167343)
Xiao-Feng He (456180)

May 2018

Figure S1. Immunohistochemically staining of PD-L1 proteins in patients with hepatocellular carcinom...

Additional file 2: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing (6477710)
Yi-Peng Fu (6477713)
Yong Yi (147488)
Mei-Xia Zhang (6477716)
Su-Su Zheng (422272)
Jin-Long Huang (599641)
Wei Gan (172146)
Xin Xu (11989)
Jia-Jia Lin (6477719)
Juan Zhang (48597)
Shuang-Jian Qiu (157512)
Bo-Heng Zhang (422274)

March 2019

Table S2. Univariate and multivariate analyses of prognostic factors correlated with RFS (DOCX 16 kb

Additional file 5: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing (6477710)
Yi-Peng Fu (6477713)
Yong Yi (147488)
Mei-Xia Zhang (6477716)
Su-Su Zheng (422272)
Jin-Long Huang (599641)
Wei Gan (172146)
Xin Xu (11989)
Jia-Jia Lin (6477719)
Juan Zhang (48597)
Shuang-Jian Qiu (157512)
Bo-Heng Zhang (422274)

March 2019

Table S5. Infiltrating patterns of immune cells with different PD-L1 expression on IC (DOCX 16 kb

Additional file 4: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing (6477710)
Yi-Peng Fu (6477713)
Yong Yi (147488)
Mei-Xia Zhang (6477716)
Su-Su Zheng (422272)
Jin-Long Huang (599641)
Wei Gan (172146)
Xin Xu (11989)
Jia-Jia Lin (6477719)
Juan Zhang (48597)
Shuang-Jian Qiu (157512)
Bo-Heng Zhang (422274)

March 2019

Table S4. Correlation between PD-L1 expression on TC and different immune infiltrates (DOCX 16 kb

Additional file 3: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing (6477710)
Yi-Peng Fu (6477713)
Yong Yi (147488)
Mei-Xia Zhang (6477716)
Su-Su Zheng (422272)
Jin-Long Huang (599641)
Wei Gan (172146)
Xin Xu (11989)
Jia-Jia Lin (6477719)
Juan Zhang (48597)
Shuang-Jian Qiu (157512)
Bo-Heng Zhang (422274)

March 2019

Table S3. Correlation between HHLA2 expression and different immune infiltrates (DOCX 16 kb

Additional file 1: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing (6477710)
Yi-Peng Fu (6477713)
Yong Yi (147488)
Mei-Xia Zhang (6477716)
Su-Su Zheng (422272)
Jin-Long Huang (599641)
Wei Gan (172146)
Xin Xu (11989)
Jia-Jia Lin (6477719)
Juan Zhang (48597)
Shuang-Jian Qiu (157512)
Bo-Heng Zhang (422274)

March 2019

Table S1. Correlation between PD-L1 expression and baseline clinicopathological features in ICC (DOC...

HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Chu-Yu Jing
Yi-Peng Fu
Yong Yi
Mei-Xia Zhang
Su-Su Zheng
Jin-Long Huang
Wei Gan
Xin Xu
Jia-Jia Lin
Juan Zhang
Shuang-Jian Qiu
Bo-Heng Zhang

March 2019

Abstract Background Intrahepatic cholangiocarcinoma (ICC) is a highly mortal malignancy with limited...

Additional file 5 of Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis

Long Liu (390523)
Qi Wang (22418)
Linjun Wu (14680456)
Lele Zhang (388913)
Yuxi Huang (14160785)
Haihua Yang (728858)
Le guo (16550040)
Zheping Fang (16550043)
Xuequan Wang (697301)

July 2023

Additional Figure S4: Immune cell type expression analysis results of POLA2 based on HPA, Monaco, an...

Additional file 1: of Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

Mark Kriegsmann (3485276)
Stephanie Roessler (479270)
Katharina Kriegsmann (6210830)
Marcus Renner (3097578)
Rémi Longuespée (3858949)
Thomas Albrecht (361635)
Moritz Loeffler (6210842)
Stephan Singer (3404138)
Arianeb Mehrabi (3097584)
Monika Vogel (6210848)
Anita Pathil (3097575)
Bruno Köhler (6210851)
Christoph Springfeld (6210854)
Christian Rupp (188332)
Karl Weiss (471420)
Benjamin Goeppert (539472)

January 2019

Figure S1. Example of a typical staining pattern of on-slide control tissues (PD-L1, SP263). Tonsill...

PD-L1 and HLA class i antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma

Sabbatino, Francesco
Villani, Vincenzo
Yearley, Jennifer H.
Deshpande, Vikram
Cai, Lei
Konstantinidis, Ioannis T.
Moon, Christina
Nota, Sjoerd
Wang, Yangyang
Al-Sukaini, Ahmad
Zhu, Andrew X.
Goyal, Lipika
Ting, David T.
Bardeesy, Nabeel
Hong, Theodore S.
Castillo, Carlos Fernandez-Del
Tanabe, Kenneth K.
Lillemoe, Keith D.
Ferrone, Soldano
Ferrone, Cristina R.

January 2016

Purpose: More effective therapy is needed for intrahepatic cholangiocarcinoma (ICC). The encouraging...

Additional file 2: Table S1. of PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma

Guanzhen Yu (781304)
Wenlong Yu (1600288)
Guangzhi Jin (3767215)
Dongyun Xu (3767218)
Ying Chen (9697)
Tian Xia (139140)
Allan Yu (3767221)
Wenzheng Fang (2098036)
Xiaoli Zhang (135098)
Zhaosheng Li (1465150)
Keping Xie (306727)

November 2015

Association between expression of PKM2, PFKB, and HK1 and clinical variables in HC patients. Table S...

Additional file 1: of Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling

Yan Wang (15435)
Yingjian Liang (300784)
Guangchao Yang (5225111)
Yaliang Lan (5225114)
Jihua Han (813010)
Jiabei Wang (345448)
Dalong Yin (345445)
Ruipeng Song (300788)
Tongsen Zheng (345447)
Shugeng Zhang (6050306)
Shangha Pan (201039)
Xirui Liu (5225102)
Mingxi Zhu (5225108)
Yao Liu (173014)
Yifeng Cui (5225105)
Fanzheng Meng (635696)
Bo Zhang (6559)
Shuhang Liang (6050309)
Hongrui Guo (6050312)
Yufeng Liu (307498)
Md Hassan (6050315)
Lianxin Liu (300790)

December 2018

Table S1. Target sequences of vshRNAs used in this study. Table S2. Primary antibodies for WB, IHC, ...

Additional file 2 of Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis

Long Liu (390523)
Qi Wang (22418)
Linjun Wu (14680456)
Lele Zhang (388913)
Yuxi Huang (14160785)
Haihua Yang (728858)
Le guo (16550040)
Zheping Fang (16550043)
Xuequan Wang (697301)

July 2023

Additional Figure S1: The high expression of POLA1 and POLA2 in hepatocellular carcinoma analyzed by...

Additional file 4: Figure S2. of CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma

Li Li (14993)
Li Xu (108702)
Jing Yan (312090)
Zuo-Jun Zhen (642826)
Yong Ji (296783)
Chao-Qun Liu (642825)
Wan Lau (3485807)
Limin Zheng (385489)
Jing Xu (1234089)

October 2015

The number of CD15+, CD68+, CD3+, and S100+ cells in different regions of HCC tissues. Paraffin-embe...

Additional file 3 of Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis

Long Liu (390523)
Qi Wang (22418)
Linjun Wu (14680456)
Lele Zhang (388913)
Yuxi Huang (14160785)
Haihua Yang (728858)
Le guo (16550040)
Zheping Fang (16550043)
Xuequan Wang (697301)

July 2023

Additional Figure S2: (A) Co-expression analysis of POLA1 and POLA2; (B) ROC diagnostic curve of POL...

Additional file 2: of VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma

Ming Zhang (9736)
Hua-Jin Pang (5167337)
Wei Zhao (14321)
Yu-Fa Li (5167340)
Li-Xu Yan (223343)
Zhong-Yi Dong (5167343)
Xiao-Feng He (456180)

May 2018

Figure S1. Immunohistochemically staining of PD-L1 proteins in patients with hepatocellular carcinom...

Additional file 6: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Abstract

Extracted data

Additional file 6: of HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Abstract

Extracted data

Related items

Related items